Hot Topics in NASH

Expert faculty present key data on new NASH/NAFLD studies, diagnostic tools, and treatment options for your patients.

Kenneth Cusi, MD, FACP, FACE
Program Director Brent A. Neuschwander-Tetri, MD Released: December 6, 2018

Expert hepatologist presents key data on new NASH/NAFLD studies, diagnostic tools, and treatment options for your patients.

Brent A. Neuschwander-Tetri, MD Released: December 13, 2018

Expert endocrinologist presents key data on new NASH/NAFLD studies, diagnostic tools, and treatment options for your patients.

Kenneth Cusi, MD, FACP, FACE
Program Director Released: December 13, 2018

Expert faculty present key data on current and emerging NASH treatment options for your patients

Juan Pablo Frias, MD, FACE Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: January 18, 2019

Expert hepatologist presents key data on current and emerging NASH treatment options for your patients

Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: January 18, 2019

Expert endocrinologist presents key data on current and emerging NASH treatment options for your patients

Juan Pablo Frias, MD, FACE Released: January 22, 2019

Expert faculty present key data on current and emerging NASH treatment options for your patients.

Rita Basu, MD Wing-Kin Syn, MBChB, PhD, FACP, FRCP Released: February 11, 2019

Expert endocrinologist presents current and emerging approaches to identifying NASH and significant fibrosis.

Rita Basu, MD Released: February 13, 2019

Expert hepatologist presents current and emerging approaches to identifying NASH and significant fibrosis.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Released: February 15, 2019

Expert faculty present key data on the potential roles of weight loss and antidiabetic drugs for your patients with NASH

Philip N. Newsome, PhD, FRCPE Raymond E. Soccio, MD, PhD Released: March 5, 2019

Expert hepatologist presents key data on the potential roles of weight loss and antidiabetic drugs for your patients with NASH

Philip N. Newsome, PhD, FRCPE Released: March 6, 2019

Expert endocrinologist presents key data on the potential roles of weight loss and antidiabetic drugs for your patients with NASH

Raymond E. Soccio, MD, PhD Released: March 7, 2019

Expert faculty explain how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Kenneth Cusi, MD, FACP, FACE
Program Director Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: March 26, 2019

Expert hepatologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: March 29, 2019

Expert endocrinologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Kenneth Cusi, MD, FACP, FACE
Program Director Released: March 29, 2019